Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Oct 2010;18(5):357-62
Focus Areas / Session Topics Clinical Endocrinology Molecular Endocrinology Endocrine Oncology, Endocrine Connections Hypertension Diabetes, Endocrine and Metabolism Obesity Cardiovascular Disorders Neuroendocrine Pediatric Endocrine Nutrition and Lifestyle Thyroid Disorders Reproductive endocrinology Diabetes, Obesity, Metabolism and Nutrition Calcium and Bone Adrenal and Cardiovascular Endocrinology Environmental Endocrinology Clinical Endocrinology Endocrine related Cancer and Tumors Neuroendocrinology and NET (neuroendocrine tumor) Reproductive and Development Endocrinology Thyroid Cardiovascular medicine Precision Medicine Transgender Medicine and Research Endocrinology and Genetics Aim: Optimized life-long health for people with endocrine disorders worldwide
This is why vial size selection matters
Important Considerations for Patients Who Have Undergone Metabolic or Bariatric Surgery Patients who have had metabolic or bariatric surgery should have a separate and specific discussion before starting a GLP 1 receptor agonist as part of Obesity Management Medication therapy
:max_bytes(150000):strip_icc()/26Q1_WL_oral-sema_newsroom_1920x1008-1dfa18327b724266bed50c36ab0b9d49.jpg)
